SEGMENT REPORTING (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

Certain information concerning the Company’s segments is presented in the following tables (in thousands):

	For the Three Months Ended
	March 31,
	2023			2022
Net revenues:
Reportable segments:
Regenerative medicine	$	—		$	—
Contract services		—			741
Total net revenues	$	—		$	741
Net (loss)/income:
Reportable segments:
Regenerative medicine	$	(4,243	)	$	(3,545	)
Contract services		—			(226	)
Total net loss	$	(4,243	)	$	(3,771	)